Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSRIC. Diazoxide choline controlled-release for Prader-Willi syndrome – first line. Birmingham: NIHR Horizon Scanning Research&Intelligence Centre. Horizon Scanning Review. 2016 Authors' conclusions Diazoxide choline is a new drug to treat Prader-Willi syndrome. Prader-Willi syndrome is a rare genetic disorder that causes people to eat uncontrollably and become obese. It may also cause learning difficulties and behavioural problems. Diazoxide choline is a slow release tablet that is taken by mouth. Some studies have suggested that diazoxide choline may help people with Prader-Willi syndrome to control their eating. Indexing Status Subject indexing assigned by CRD MeSH Choline; Chromosomes, Human, Pair 15; Delayed-Action Preparations; Diazoxide; Humans; Prader-Willi Syndrome Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence NIHR Horizon Scanning Research&Intelligence Centre, University of Birmingham, Institute of Applied Health Research, Public Health building, Edgbaston, Birmingham B15 2TT
Tel: 0121 414 9077 Email: nihrhsc@contacts.bham.ac.uk AccessionNumber 32016001033 Date abstract record published 11/10/2016 |